Bavarian Nordic — Juni 2023
-
GSK Plc: New Data Shows Vaccine Efficacy Of Arexvy Against RSV-lower Respiratory Tract Disease https://www.proinvestor.com/investornyt/1003672/gsk-plc-new-data-shows-vaccine-efficacy-of-arexvy-against-rsv-lower-respiratory-tract-disease
-
Chikungunya Fever Market is Projected to Reach USD 1.98 Billion by 2027 https://www.researchandmarkets.com/reports/5271488/global-chikungunya-fever-market-by-diagnosis. Er dette blev delt tidligere? Her ser de umiddelbart et større marked om 4 år...
-
Bavarian selv estimerer med et salg på ca. 500 mio. kr.
-
..på slide 12 her, skriver de 500 mio. $ i 2032, men måske en noget forældet slide, https://www.bavarian-nordic.com/media/323460/230215_conference_call.pdf
-
..estimated launch i 2025
-
Tak for præciseringen
-
Link til investeringspodcasten virker hos mig - kan ikke finde serveren?
-
Bavarian skriver selv i deres rapportering fra conference call Q1, at der ikke er indregnet negativ driftspåvirkning for 400 mio. kr. og dette først vil ske efter overtagelsen og seneste ved Q2 rapportering.
-
Godmorgen
-
GSK : CDC's Panel Votes To Recommend Arexvy For Prevention Of RSV Disease In Older Adults https://www.proinvestor.com/investornyt/1004230/gsk-cdcs-panel-votes-to-recommend-arexvy-for-prevention-of-rsv-disease-in-older-adults
-
Shortpositioner på danske aktier https://www.proinvestor.com/boards/113361
-
Det er korrekt @YPE, men i en af de seneste udmeldinger fra Chaplin, som f.eks. i denne artikel fra CNN Health (https://edition.cnn.com/2023/05/03/health/first-rsv-vaccine-approved/index.html) skriver de: "Bavarian Nordic, maker of the Jynneos mpox vaccine, says it will report results from a Phase 3 trial of its RSV vaccine for older adults this year.". This year kan selvfølgelig betyde medio 2023, men også december 2023... så det kan enten være, at artiklen er skrevet lidt misvisende eller at
-
(fort.) Bavarian bevidst siger "this year" for at være på den sikre side.
-
Jeg vil tillade mig at skrive til Rolf og høre, om de kan præcisere nærmere..
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind